FDA Chief resigns. We called for his scalp two weeks ago.

Take Action: New FDA head must make vaccine safety a priority

    On February 22 the Autism Action Network called for the President to fire Food and Drug Administration Commissioner Scott Gottlieb for supporting federal action to eliminate vaccine exemption rights if the states refuse to do so. Yesterday, Gottlieb announced that he was resigning to, “spend more time with his family.” And he did so on the same day that the US Senate Health, Education, Labor and Pensions Committee held a hearing on vaccine policy that was highly critical of exemption rights. Coincidence? Perhaps. Regardless, Gottlieb is gone.

    If you support the results-driven advocacy of  the Autism Action Network please make a donation so we can continue fighting for you and your family here: https://grouprev.com/autismactionnetwork2018

    This is a perfect opportunity for the President to appoint a new FDA head who will move vaccine safety analysis beyond the current lax standards, and embrace common-sense safety procedures that are already standard-operating procedures for drugs, but not vaccines.

   Please click on the Take Action link to send a message to the President requesting the appointment of a new FDA chief who will place vaccine safety at the top of the agency’s priorities.

    And please call the White House and politely ask for the same: (202) 456-1111

Here are some no-brainer policies we need to adopt or change:

• The universally recognized “gold standard” for testing the efficacy and safety of drugs and vaccines is a double-blind placebo-controlled test. Meaning an inert placebo is given to a test group, and the drug being tested is given to another group, and the people administering the drug don’t know whether they are giving the placebo or the drug. This is standard practice with drugs. But not vaccines. Think about that. We do not require the highest standards of safety to analyze products intended to be injected into every child in the world.
• Inert placebos are not used. A placebo needs to be as inert and innocuous as possible. But it is standard practice in the vaccine industry to use solutions containing the adjuvant used in the vaccine, usually aluminum or other substances known to be highly toxic, or even another vaccine, as the placebo.
• Multiple vaccines are administered at the same time to our children, but there is no requirement to analyze the safety of giving several vaccines at the same time.
• Long-term follow-up to assess the safety of vaccines is conducted on a haphazard basis. Some mandatory vaccines were only followed for days after injection.
• Adverse events suffered by test subjects during safety analysis studies are routinely disregarded for arbitrary reasons and not used to assess the safety of the product.

    Please share this message with friends and family, and please post to social networks.